The FDA announced on Feb. 18, 2015, that Mylan Institutional LLC voluntarily recalled Haloperidol Decanoate Injection due to a lack of sterility assurance caused by leaking vials. The agency classified the recall as Class II.
How to tell if you have it
- Brand: Mylan Institutional
- Product: Haloperidol Decanoate Injection, 100 mg/mL, For Intra Muscular Use Only, 1 mL single dose vials
- NDC: 67457-409-00 (vials), 67457-409-13 (cartons of five)
- Lot codes: 7602281, 7602283
- Expiration dates: 4/16
- Distribution: Nationwide and Puerto Rico
The hazard
The recall addresses a lack of assurance of sterility due to leaking vials. The FDA classified the action as Class II.
Context
GovInfoNow's records show Mylan Institutional LLC has 10 other recalls on record since Jan. 23, 2015. Other recent recalls include a May 3, 2021 labeling error for Thiamine HCl Injection and an Aug. 17, 2020 label mix-up risk for Amiodarone Injection. Similar products have faced sterility issues, including a July 2, 2026 recall of Mycophenolate Mofetil Injection for precipitate risk and a Sept. 10, 2026 Quad-Mix Injectable recall by Carolina Infusion.